Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
37.1M
-
Shares change
-
+2.08M
-
Total reported value, excl. options
-
$165M
-
Value change
-
+$9.87M
-
Put/Call ratio
-
3.8
-
Number of buys
-
46
-
Number of sells
-
-15
-
Price
-
$4.45
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q3 2019
78 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q3 2019.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.1M shares
of 237M outstanding shares and own 15.66% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (11.5M shares), Consonance Capital Management LP (5.11M shares), Aisling Capital LLC (3.61M shares), BlackRock Inc. (3.15M shares), VANGUARD GROUP INC (2.19M shares), Schonfeld Strategic Advisors LLC (1.57M shares), 683 Capital Management, LLC (1.42M shares), MILLENNIUM MANAGEMENT LLC (863K shares), STATE STREET CORP (696K shares), and NORTHERN TRUST CORP (636K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.